top of page
History
2019
History
06 Founded ImmunoBiome, Inc.
07 Seed Financing
10 Obtained certification of a
Venture company
12 Pre-A Series Financing
Technology transfers from
IBS and POSTECH
2020
02 Established the corporate
affiliated research center
08 Moved the headquarters to Bio
Open Innovation Center
09 Series-A Financing
10 Signed CDMO contract with Biose
Industrie, a French company
2021
05 Conducted pre-clinical study for
IMB002
06 Completed pre-clinical study for
IMB001
09 MOU for co-development with Hy
(former Korea Yogurt)
2022
08 IMB002 Preclinical trial
completion
10 IMB002 cGMP production
completion
What's Next?
bottom of page